Combined drug repurposing and virtual screening strategies with molecular dynamics simulation identified potent inhibitors for SARS-CoV-2 main protease (3CLpro)

References

• Bosch, B. J., van der Zee, R., de Haan, C. A., & Rottier, P. J. (2003). The coronavirus spike protein is a class I virus fusion protein: Structural and functional characterization of the fusion core complex. Journal of Virology, 77(16), 8801–8811. https://doi.org/10.1128/jvi.77.16.8801-8811.2003
   PubMed Web of Science ®Google Scholar
• Case, D. A., Cheatham, T. E., Darden, T., Gohlke, H., Luo, R., Merz, K. M., Onufriev, A., Simmerling, C., Wang, B., & Woods, R. J. (2005). The Amber biomolecular simulation programs. Journal of Computational Chemistry, 26(16), 1668–1688. https://doi.org/10.1002/jcc.20290
   PubMed Web of Science ®Google Scholar
• Chan, J. F. W., Chan, K.-H., Kao, R. Y. T., To, K. K. W., Zheng, B.-J., Li, C. P. Y., Li, P. T. W., Dai, J., Mok, F. K. Y., Chen, H., Hayden, F. G., & Yuen, K.-Y. (2013). Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus. The Journal of Infection, 67(6), 606–616. https://doi.org/10.1016/j.jinf.2013.09.029
   PubMed Web of Science ®Google Scholar
• Chen, F., Liu, H., Sun, H., Pan, P., Li, Y., Li, D., & Hou, T. (2016). Assessing the performance of the MM/PBSA and MM/GBSA methods. 6. Capability to predict protein-protein binding free energies and re-rank binding poses generated by protein-protein docking. Physical Chemistry Chemical Physics: PCCP, 18(32), 22129–22139. https://doi.org/10.1039/c6cp03670h
   PubMed Web of Science ®Google Scholar
• Chen, H., & Du, Q. (2020). Potential natural compounds for preventing SARS-CoV-2 (2019-nCoV) infection. Preprints, 92, 1–17.
   Google Scholar
• Chen, Y., Liu, Q., & Guo, D. (2020). Emerging coronaviruses: Genome structure, replication, and pathogenesis. Journal of Medical Virology, 92(4), 418–423. https://doi.org/10.1002/jmv.25681
   PubMed Web of Science ®Google Scholar
• Cheng, V. C., Lau, S. K., Woo, P. C., & Yuen, K. Y. (2007). Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection. Clinical Microbiology Reviews, 20(4), 660–694. https://doi.org/10.1128/CMR.00023-07
   PubMed Web of Science ®Google Scholar
• Dai, W., Zhang, B., Jiang, X.-M., Su, H., Li, J., Zhao, Y., Xie, X., Jin, Z., Peng, J., Liu, F., Li, C., Li, Y., Bai, F., Wang, H., Chen, X., Cen, X., Hu, S., Yang, X., Wang, J., … Liu, H. (2020). Structure-based design, synthesis and biological evaluation of peptidomimetic aldehydes as a novel series of antiviral drug candidates targeting the SARS-CoV-2 main protease. bioRxiv, 1–17.
   Google Scholar
• de Groot, R. J., Baker, S. C., Baric, R. S., Brown, C. S., Drosten, C., Enjuanes, L., Fouchier, R. A. M., Galiano, M., Gorbalenya, A. E., Memish, Z. A., Perlman, S., Poon, L. L. M., Snijder, E. J., Stephens, G. M., Woo, P. C. Y., Zaki, A. M., Zambon, M., & Ziebuhr, J. (2013). Commentary: Middle East respiratory syndrome coronavirus (MERS-CoV): Announcement of the Coronavirus Study Group. Journal of Virology, 87(14), 7790–7792. https://doi.org/10.1128/JVI.01244-13
   PubMed Web of Science ®Google Scholar
• de Wilde, A. H., Jochmans, D., Posthuma, C. C., Zevenhoven-Dobbe, J. C., van Nieuwkoop, S., Bestebroer, T. M., van den Hoogen, B. G., Neyts, J., & Snijder, E. J. (2014). Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture. Antimicrobial Agents and Chemotherapy, 58(8), 4875–4884. https://doi.org/10.1128/AAC.03011-14
   PubMed Web of Science ®Google Scholar
• Dyall, J., Coleman, C. M., Hart, B. J., Venkataraman, T., Holbrook, M. R., Kindrachuk, J., Johnson, R. F., Olinger, G. G., Jahrling, P. B., Laidlaw, M., Johansen, L. M., Lear-Rooney, C. M., Glass, P. J., Hensley, L. E., & Frieman, M. B. (2014). Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection. Antimicrobial Agents and Chemotherapy, 58(8), 4885–4893. https://doi.org/10.1128/AAC.03036-14
   PubMed Web of Science ®Google Scholar
• Hernandez, J. J., Pryszlak, M., Smith, L., Yanchus, C., Kurji, N., Shahani, V. M., & Molinski, S. V. (2017). Giving drugs a second chance: Overcoming regulatory and financial hurdles in repurposing approved drugs as cancer therapeutics. Frontiers in Oncology, 7, 273. https://doi.org/10.3389/fonc.2017.00273
   PubMed Web of Science ®Google Scholar
• Hou, T., Li, N., Li, Y., & Wang, W. (2012). Characterization of domain-peptide interaction interface: prediction of SH3 domain-mediated protein-protein interaction network in yeast by generic structure-based models. Journal of Proteome Research, 11(5), 2982–2995. https://doi.org/10.1021/pr3000688
   PubMed Web of Science ®Google Scholar
• Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., Cheng, Z., Yu, T., Xia, J., Wei, Y., Wu, W., Xie, X., Yin, W., Li, H., Liu, M., … Cao, B. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan. The Lancet, 395(10223), 497–506. https://doi.org/10.1016/S0140-6736(20)30183-5
   PubMed Web of Science ®Google Scholar
• Jin, Z., Du, X., Xu, Y., Deng, Y., Liu, M., Zhao, Y., Zhang, B., Li, X., Zhang, L., Peng, C., Duan, Y., Yu, J., Wang, L., Yang, K., Liu, F., Jiang, R., Yang, X., You, T., Liu, X., … Yang, H. (2020). Structure of Mpro from COVID-19 virus and discovery of its inhibitors. bioRxiv, 1–33.
   Google Scholar
• Khan, A., Kaushik, A. C., Ali, S. S., Ahmad, N., & Wei, D.-Q. (2019). Deep-learning-based target screening and similarity search for the predicted inhibitors of the pathways in Parkinson’s disease. RSC Advances, 9(18), 10326–10339. https://doi.org/10.1039/C9RA01007F
   PubMed Web of Science ®Google Scholar
• Khan, A., Saleem, S., Idrees, M., Ali, S. S., Junaid, M., Kaushik, A. C., & Wei, D.-Q. (2018). Allosteric ligands for the pharmacologically important Flavivirus target (NS5) from ZINC database based on pharmacophoric points, free energy calculations and dynamics correlation. Journal of Molecular Graphics & Modelling, 82, 37–47. https://doi.org/10.1016/j.jmgm.2018.03.004
   PubMed Web of Science ®Google Scholar
• Khan, S. A., Zia, K., Ashraf, S., Uddin, R., & Ul-Haq, Z. (2020). Identification of Chymotrypsin-like protease inhibitors of SARS-CoV-2 via integrated computational approach. Journal of Biomolecular Structure and Dynamics, 38, 1–13.
   PubMed Web of Science ®Google Scholar
• Kim, A. E., Dintaman, J. M., Waddell, D. S., & Silverman, J. A. (1998). Saquinavir, an HIV protease inhibitor, is transported by P-glycoprotein. The Journal of Pharmacology and Experimental Therapeutics, 286(3), 1439–1445.
   PubMed Web of Science ®Google Scholar
• Lau, S. K. P., Woo, P. C. Y., Li, K. S. M., Huang, Y., Tsoi, H.-W., Wong, B. H. L., Wong, S. S. Y., Leung, S.-Y., Chan, K.-H., & Yuen, K.-Y. (2005). Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats. Proceedings of the National Academy of Sciences of the United States of America, 102(39), 14040–14045. https://doi.org/10.1073/pnas.0506735102
   PubMed Web of Science ®Google Scholar
• Lee, N., Hui, D., Wu, A., Chan, P., Cameron, P., Joynt, G. M., Ahuja, A., Yung, M. Y., Leung, C. B., To, K. F., Lui, S. F., Szeto, C. C., Chung, S., & Sung, J. J. Y. (2003). A major outbreak of severe acute respiratory syndrome in Hong Kong. The New England Journal of Medicine, 348(20), 1986–1994. https://doi.org/10.1056/NEJMoa030685
   PubMed Web of Science ®Google Scholar
• Lerner, M., & Carlson, H. (2006). APBS plugin for PyMOL. University of Michigan.
   Google Scholar
• Miller III, B. R., McGee, T. D., Jr, Swails, J. M., Homeyer, N., Gohlke, H., & Roitberg, A. E. (2012). MMPBSA.py: An efficient program for end-state free energy calculations. Journal of Chemical Theory and Computation, 8(9), 3314–3321. https://doi.org/10.1021/ct300418h
   PubMed Web of Science ®Google Scholar
• Omrani, A. S., Saad, M. M., Baig, K., Bahloul, A., Abdul-Matin, M., Alaidaroos, A. Y., Almakhlafi, G. A., Albarrak, M. M., Memish, Z. A., & Albarrak, A. M. (2014). Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: A retrospective cohort study. The Lancet. Infectious Diseases, 14(11), 1090–1095. https://doi.org/10.1016/S1473-3099(14)70920-X
   PubMed Web of Science ®Google Scholar
• Price, D. J., & Brooks III, C. L. (2004). A modified TIP3P water potential for simulation with Ewald summation. The Journal of Chemical Physics, 121(20), 10096–10103. https://doi.org/10.1063/1.1808117
   PubMed Web of Science ®Google Scholar
• Pushpakom, S., Iorio, F., Eyers, P. A., Escott, K. J., Hopper, S., Wells, A., Doig, A., Guilliams, T., Latimer, J., McNamee, C., Norris, A., Sanseau, P., Cavalla, D., & Pirmohamed, M. (2019). Drug repurposing: Progress, challenges and recommendations. Nature Reviews. Drug Discovery, 18(1), 41–58. https://doi.org/10.1038/nrd.2018.168
   PubMed Web of Science ®Google Scholar
• Release, S. (2017). Maestro. Schrödinger, LLC.
   Google Scholar
• Reusken, C. B., Haagmans, B. L., Müller, M. A., Gutierrez, C., Godeke, G.-J., Meyer, B., Muth, D., Raj, V. S., Vries, L. S.-D., Corman, V. M., Drexler, J.-F., Smits, S. L., El Tahir, Y. E., De Sousa, R., van Beek, J., Nowotny, N., van Maanen, K., Hidalgo-Hermoso, E., Bosch, B.-J., … Koopmans, M. P. (2013). Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: A comparative serological study. The Lancet Infectious Diseases, 13(10), 859–866. https://doi.org/10.1016/S1473-3099(13)70164-6
   PubMed Web of Science ®Google Scholar
• Roe, D. R., & Cheatham III, T. E. (2013). PTRAJ and CPPTRAJ: Software for processing and analysis of molecular dynamics trajectory data. Journal of Chemical Theory and Computation, 9(7), 3084–3095. https://doi.org/10.1021/ct400341p
   PubMed Web of Science ®Google Scholar
• Rose, P. W., Prlić, A., Altunkaya, A., Bi, C., Bradley, A. R., Christie, C. H., Di Costanzo, L., Duarte, J., Dutta, S., Feng, Z., Green, R. K., Goodsell, D. S., Hudson, B., Karlo, T., Lowe, R., Peisach, E., Randle, C., Rose, A. S., Shao, C., … Burley, S. K. (2016). The RCSB protein data bank: Integrative view of protein, gene and 3D structural information. Nucleic Acids Research, 45(D1), D271–D281.
   PubMed Web of Science ®Google Scholar
• Rothan, H. A., & Byrareddy, S. N. (2020). The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. Journal of Autoimmunity, 109, 102433. https://doi.org/10.1016/j.jaut.2020.102433
   PubMed Web of Science ®Google Scholar
• Schrodinger, L. (2011). Schrodinger software suite (p. 670). Schrödinger, LLC.
   Google Scholar
• Sleigh, S. H., & Barton, C. L. (2010). Repurposing strategies for therapeutics. Pharmaceutical Medicine, 24(3), 151–159. https://doi.org/10.1007/BF03256811
   Google Scholar
• Sun, H., Li, Y., Tian, S., Xu, L., & Hou, T. (2014). Assessing the performance of MM/PBSA and MM/GBSA methods. 4. Accuracies of MM/PBSA and MM/GBSA methodologies evaluated by various simulation protocols using PDBbind data set. Physical Chemistry Chemical Physics: PCCP, 16(31), 16719–16729. https://doi.org/10.1039/c4cp01388c
   PubMed Web of Science ®Google Scholar
• Ul Qamar, M. T., Alqahtani, S. M., Alamri, M. A., & Chen, L.-L. (2020). Structural basis of SARS-CoV-2 3CLpro and anti-COVID-19 drug discovery from medicinal plants. Journal of Pharmaceutical Analysis, 10, 1–7.
   PubMed Web of Science ®Google Scholar
• Wang, Y., Khan, A., Chandra Kaushik, A., Junaid, M., Zhang, X., & Wei, D.-Q. (2019). The systematic modeling studies and free energy calculations of the phenazine compounds as anti-tuberculosis agents. Journal of Biomolecular Structure & Dynamics, 37(15), 4051–4069. https://doi.org/10.1080/07391102.2018.1537896
   PubMed Web of Science ®Google Scholar
• Wishart, D. S., Feunang, Y. D., Guo, A. C., Lo, E. J., Marcu, A., Grant, J. R., Sajed, T., Johnson, D., Li, C., Sayeeda, Z., Assempour, N., Iynkkaran, I., Liu, Y., Maciejewski, A., Gale, N., Wilson, A., Chin, L., Cummings, R., Le, D., … Wilson, M. (2018). DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Research, 46(D1), D1074–D1082. https://doi.org/10.1093/nar/gkx1037
   PubMed Web of Science ®Google Scholar
• Yang, Y., Islam, M. S., Wang, J., Li, Y., & Chen, X. (2020). Traditional Chinese medicine in the treatment of patients infected with 2019-new coronavirus (SARS-CoV-2): a review and perspective. International Journal of Biological Sciences, 16(10), 1708–1717. https://doi.org/10.7150/ijbs.45538
   PubMed Web of Science ®Google Scholar
• Zaki, A. M., Van Boheemen, S., Bestebroer, T. M., Osterhaus, A. D., & Fouchier, R. A. (2012). Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. The New England Journal of Medicine, 367(19), 1814–1820. https://doi.org/10.1056/NEJMoa1211721
   PubMed Web of Science ®Google Scholar
• Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., Niu, P., Zhan, F., Ma, X., Wang, D., Xu, W., Wu, G., Gao, G. F., & Tan, W. (2020). A novel coronavirus from patients with pneumonia in China, 2019. The New England Journal of Medicine, 382(8), 727–733.
   PubMed Web of Science ®Google Scholar
• Zumla, A., Chan, J. F., Azhar, E. I., Hui, D. S., & Yuen, K.-Y. (2016). Coronaviruses - drug discovery and therapeutic options. Nature Reviews. Drug Discovery, 15(5), 327–347. https://doi.org/10.1038/nrd.2015.37
   PubMed Web of Science ®Google Scholar